Acute dystonia resulting from abrupt bupropion discontinuation

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 31, Issue 3, 2007, Pages 766-768

  Wang, Hung Yu ^a   Chou, Wen Jiun ^b   Huang, Tsan Yu ^b   Hung, Chi Fa ^b  

^a KAI SUAN PSYCHIATRIC HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Acute dystonia; Bupropion; Discontinuation

Indexed keywords

AMFEBUTAMONE; BIPERIDEN; DULOXETINE; LORAZEPAM;

ADULT; ARTICLE; CASE REPORT; DIGESTIVE TRACT ENDOSCOPY; DRUG EFFECT; DRUG SUBSTITUTION; DRUG WITHDRAWAL; DYSPHAGIA; DYSTONIA; HUMAN; MAJOR DEPRESSION; MALE; RETREATMENT; TORTICOLLIS; TRISMUS; WITHDRAWAL SYNDROME;

ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BUPROPION; DEPRESSIVE DISORDER, MAJOR; DYSTONIA; HUMANS; MALE; MIDDLE AGED; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 33947510529     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2006.12.003     Document Type: Article

References (18)

1. Bateman D.N., Darling W.M., Boys R., and Rawlins M.D. Extrapyramidal reactions to metoclopramide and prochloperazine. Q J Med 71 (1989) 307-311
2. Carter G. The abrupt withdrawal of antiparkinsonian drugs in mentally handicapped patients. Br J Psychiatry 142 (1983) 166-168
3. Casey D.E. Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 65 Suppl. 9 (2004) 25-28
4. Detweiler M.B., and Harpold G.J. Bupropion-induced acute dystonia. Ann Pharmacother 36 (2002) 251-254
5. Ferris R.M., Cooper B.R., and Maxwell R.A. Studies of bupropion's mechanism of antidepressant activity. J Clin Psychiatry 44 (1983) 74-78
6. Hamilton M.S., and Opler L.A. Akathisia, suicidality and fluoxetine. J Clin Psychiatry 53 (1992) 401-406
7. Kaiser R., Tremblay P.B., Klufmoller F., Roots I., and Brockmoller J. Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia. Mol Psychiatry 7 (2002) 695-705
8. Keepers G.A., and Casey D.E. Prediction of neuroleptic-induced dystonia. J Clin Psychopharmacol 7 (1987) 342-345
9. Leo R.J. Movement disorders associated with the serotonin selective reuptake inhibitors. J Clin Psychiatry 57 (1996) 449-454
10. Marsden C.D., and Jenner P. The pathophysiology of extrapyramidal side-effects of neuroleptic drugs. Psychol Med 10 (1980) 55-72
11. Perlmutter J.S., Tempel L.W., Black K.J., Parkinson D., and Todd R.D. MPTP induces dystonia and parkinsonism. Clues to the pathophysiology of dystonia. Neurology 49 (1997) 1432-1438
12. Rupniak N.M., Jenner P., and Marsden C.D. Acute dystonia induced by neuroleptic drugs. Psychopharmacology (Berl) 88 (1986) 403-419
13. Song X., Hu Z., and Zhang H. Acute dystonia induced by lamivudine. Clin Neuropharmacol 28 (2005) 193-194
14. Strouse T.B., Salehmoghaddam S., and Spar J.E. Acute delirium and parkinsonism in a bupropion-treated liver transplant recipient. J Clin Psychiatry 54 (1993) 489-490
15. Tarsy D., Baldessarini R.J., and Tarazi F.I. Effects of newer antipsychotics on extrapyramidal function. CNS Drugs 16 (2002) 23-45
16. Tong E.K., Carmody T.P., and Simon J.A. Bupropion for smoking cessation: a review. Compr Ther 32 (2006) 26-33
17. Vaamonde J., Gonzalez J.M., Hernadez A., Ibanez R., Gudin M.A., and Del Real Francia M.A. Writer's cramp induced by olanzapine. J Neurol 248 (2001) 422
18. van Harten P.N., Hoek H.W., and Kahn R.S. Acute dystonia induced by drug treatment. BMJ 319 (1999) 623-626